Sanofi Stock Euronext Paris
Stocks
SANNV
FR001400M6Z3
Pharmaceuticals
OTC Markets Traded| Market Cap | 100B 112B 91.69B 83.7B 158B 10,515B 163B 1,105B 441B 5,611B 420B 411B 17,712B | P/E 2026 * |
13.2x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 112B 125B 102B 93.41B 176B 11,735B 182B 1,233B 492B 6,262B 469B 459B 19,768B | EV / Sales 2026 * |
2.29x | EV / Sales 2027 * | 2.12x |
| Free-Float |
88.8% | Yield 2026 * |
5.09% | Yield 2027 * | 5.37% |
Last Transcript: Sanofi
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 112B | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.08% | -1.54% | +40.62% | +76.77% | 464.42B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +88.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48.81B 54.42B 44.61B 40.72B 76.73B 5,116B 79.14B 538B 214B 2,730B 204B 200B 8,618B | 51.38B 57.29B 46.96B 42.86B 80.76B 5,385B 83.31B 566B 226B 2,873B 215B 210B 9,071B |
| Net income | 7.74B 8.63B 7.07B 6.46B 12.16B 811B 12.55B 85.25B 33.99B 433B 32.39B 31.69B 1,366B | 9.18B 10.23B 8.39B 7.66B 14.42B 962B 14.88B 101B 40.31B 513B 38.4B 37.58B 1,620B |
| Net Debt | 11.64B 12.98B 10.64B 9.71B 18.3B 1,220B 18.88B 128B 51.14B 651B 48.73B 47.68B 2,056B | 8.82B 9.84B 8.06B 7.36B 13.87B 925B 14.31B 97.21B 38.76B 493B 36.93B 36.14B 1,558B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
